Antiviral Activity of Nobiletin against Chikungunya virus in vitro

  title={Antiviral Activity of Nobiletin against Chikungunya virus in vitro},
  author={Shih-Chao Lin and Mei-Chun Chen and Shiming Li and Chi-Chen Lin and Tony T. Wang},
  journal={Antiviral Therapy},
  pages={689 - 697}
Background Chikungunya virus (CHIKV), a highly contagious re-emerging virus, is transmitted by infected mosquitoes. CHIKV is prevalent in tropical countries and is continuing to creep farther north into temperate areas. CHIKV is responsible for induction of chikungunya fever (CF) and severe joint stiffness with the capability of developing into bilateral and systemic arthralgia or even encephalitis. Despite the high morbidity rate, no approved antiviral drug is available. Therefore, an anti… 

Figures from this paper

In Vitro Antiviral Activity of Potential Medicinal Plant Extracts Against Dengue and Chikungunya Viruses

In vitro antiviral screening of plant extracts prepared from the plants of Vitex negundo, Plumeria alba, Ancistrocladus heyneanus, Bacopa monnieri, Anacardium occidentale, Cucurbita maxima showed both anti-DENV and CHIKV activity, and these extracts can be further characterized for finding effective phytopharmaceutical drugs against dengue and chikungunya.

Detection of the antiviral activity of epicatechin isolated from Salacia crassifolia (Celastraceae) against Mayaro virus based on protein C homology modelling and virtual screening

A three-dimensional model of protein C of MAYV was constructed by homology modelling in a manner similar to that of receptors in virtual screening studies to evaluate 590 molecules as prospective antiviral agents, and epicatechin was found to be twice as potent as the reference antiviral ribavirin.

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review

This review focuses on data from in vitro studies analyzing the effects of flavonoids on various key SARS-CoV-2 targets and presents an analysis of the structure-activity relationships for the same.

An antiviral drug screening system for enterovirus 71 based on an improved plaque assay: A potential high‐throughput method

It is shown that using a subclone of a clinical EV‐A71 isolate and a rhabdomyosarcoma cell line (RD), a plaque assay based on an EV‐ a71/RD model could exhibit the most rapid formation of plaques, with much higher repeatability and consistency.

The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review

The clinical application of Citrus folium and NOB as new cancer treatment drugs requires in vivo verification and further anticancer mechanism research, and a reference for the treatment of breast cancer by Chinese medicine is provided.

Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens

Resveratrol was found to potentiate colistin activity against a wide panel of colist in-resistant strains, regardless of species and resistance mechanisms, which would deserve further investigation for potential clinical applications.

Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin

This review is a thorough review of various formulation development strategies with advances made in the past years to improve the solubility, bioavailability, and therapeutic efficacy of NOB.

Nobiletin Inhibits Inflammatory Reaction in Interleukin-1β-Stimulated Human Periodontal Ligament Cells

Findings indicate that nobiletin could inhibit inflammatory reactions in IL-1β-stimulated HPDLCs by inhibiting multiple signal transduction pathways, including NF-κB, MAPKs, and Akt pathways.

The Potential of Selected Agri-Food Loss and Waste to Contribute to a Circular Economy: Applications in the Food, Cosmetic and Pharmaceutical Industries

This paper systematically reviewed literature with different food loss and waste by-products as animal feed, cosmetic, and pharmaceutical products that strongly contribute to the paradigm shift to a circular economy, with the potential in SARS-CoV-2 disease and bacterial diseases treatment.



Antiviral activity of selected flavonoids against Chikungunya virus.

Antiviral Strategies Against Chikungunya Virus

The current status of the development of antiviral strategies against CHIKV infections is summarized, which consists of the administration of analgesics, antipyretics, and anti-inflammatory agents.

Chikungunya Virus Infection

The globalization of CHIKV exposes countries with Aedes mosquitoes both to brutal outbreaks of acute incapacitating episodes and endemic long-lasting disorders.

A Pathogenic Role for CD4+ T Cells during Chikungunya Virus Infection in Mice

Observations strongly indicate that mechanisms of joint pathology induced by CHIKV in mice resemble those in humans and differ from infections caused by other arthritogenic viruses, such as Ross River virus.

Active Infection of Human Blood Monocytes by Chikungunya Virus Triggers an Innate Immune Response

It is demonstrated for the first time that CHIKV Ags could be detected in vivo in the monocytes of acutely infected patients, and monocytes could be infected and virus growth could be sustained, and a better understanding on the basic mechanisms of infection and early antiviral immune responses is provided.

Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection Is Controlled by the Adaptive Immune Response

It is suggested that chronic musculoskeletal tissue pathology is caused by persistent Chikungunya virus infection and controlled by adaptive immune responses, and the development of strategies to mitigate the disease burden associated with CHIKV infection in humans.

Chikungunya virus and prospects for a vaccine

The challenges to the development of a safe, effective and affordable chikungunya vaccine are discussed and recent progress toward this goal is discussed.

Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.

These studies illustrate the promise of RBV plus IFN alfa as a potential therapeutic strategy for the treatment of CHIKV infections and validate the prediction made by the mathematical model.

Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses.

(S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol showed antiviral activity in monolayer tissue culture systems against 55 strains of rhinovirus, three types of poliovirus, and strains of type